All the pharmaceutical products used in the context of the anti-Covid-19 therapeutic protocol are available, assured the Ministry of the Pharmaceutical Industry on Tuesday in a press release addressed to prescribers, pharmacists and patients.
For pharmaceutical products whose availability is assured, the press release cites, in particular, anti-coagulants such as Enoxaparin, Paracetamol, Amoxicillin and Vitamin D.
In detail, the quantities available on the market are more than 2.1 million sales units (SU), during the period from November 1, 2021 to January 13, 2022, for Enoxaparin-type anti-coagulants, with the planned release of more than 3.3 million SUs during the period from January 14 to February 28, 2022 (of which more than 614,000 SUs were delivered to distribution establishments during the week from January 14 to 20, 2022).
With regard to Paracetamol, the ministry reports the mobilization of 10 local producers with the marketing of more than 16 million SU during the period from November 1, 2021 to January 13, 2022, as well as the planned release of more than 19 million SU during the period from January 14 to February 28, 2022 (for the 500 mg and 1G dosages), with the marketing of 3 million boxes during the week from January 20 to 27, 2022.
For Amoxicillin (Adult Clavulanic Acid), its marketing includes more than 1.3 million SU from January 14 to February 28, 2022, while Vitamin D, it is marketed more than 4 million SU expected to manufacturing between January 20 and March 2, 2022.
Claiming to have taken “anticipatory measures” by increasing production capacity and adjusting import or distribution programs to meet the needs in response to the Covid-19 pandemic, the ministry, however, underlined that the resurgence of contamination has generated a “very strong increase” in demand for these products.
In this regard, the ministry recalled the imperative need to “comply with the dispensation on medical prescription in order to avoid the misuse of drugs, which leads in particular to phenomena of resistance to antibiotics, hemorrhagic accidents”.
Ahmed Achour
